BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 10454744)

  • 1. A receptor for infectious and cellular prion protein.
    Martins VR
    Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
    Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
    PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular clues to pathogenesis in prion diseases.
    Laurent M; Johannin G
    Histol Histopathol; 1997 Apr; 12(2):583-94. PubMed ID: 9151145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prions amplify through degradation of the VPS10P sorting receptor sortilin.
    Uchiyama K; Tomita M; Yano M; Chida J; Hara H; Das NR; Nykjaer A; Sakaguchi S
    PLoS Pathog; 2017 Jun; 13(6):e1006470. PubMed ID: 28665987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.
    Paquet S; Daude N; Courageot MP; Chapuis J; Laude H; Vilette D
    J Virol; 2007 Oct; 81(19):10786-91. PubMed ID: 17626095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
    Bate C; Tayebi M; Williams A
    BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folding and misfolding of the prion protein in the secretory pathway.
    Tatzelt J; Winklhofer KF
    Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-genetic propagation of strain-specific properties of scrapie prion protein.
    Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
    Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
    Giese A; Kretzschmar HA
    Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
    Prasad KN; Bondy SC
    Curr Aging Sci; 2019; 11(4):216-225. PubMed ID: 30636622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
    Kumar R; McClain D; Young R; Carlson GA
    J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular isoform of the prion protein, PrPc, is associated with caveolae in mouse neuroblastoma (N2a) cells.
    Harmey JH; Doyle D; Brown V; Rogers MS
    Biochem Biophys Res Commun; 1995 May; 210(3):753-9. PubMed ID: 7763249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis.
    Glatzel M; Mohajeri MH; Poirier R; Nitsch RM; Schwarz P; Lu B; Aguzzi A
    J Gen Virol; 2005 Jun; 86(Pt 6):1861-1867. PubMed ID: 15914866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperone-supervised conversion of prion protein to its protease-resistant form.
    DebBurman SK; Raymond GJ; Caughey B; Lindquist S
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the physiological function of cellular prion protein.
    Martins VR; Mercadante AF; Cabral AL; Freitas AR; Castro RM
    Braz J Med Biol Res; 2001 May; 34(5):585-95. PubMed ID: 11323744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy.
    Veith NM; Plattner H; Stuermer CA; Schulz-Schaeffer WJ; Bürkle A
    Eur J Cell Biol; 2009 Jan; 88(1):45-63. PubMed ID: 18834644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular prion protein: biochemistry, topology, and physiologic functions.
    Griffoni C; Toni M; Spisni E; Bianco M; Santi S; Riccio M; Tomasi V
    Cell Biochem Biophys; 2003; 38(3):287-304. PubMed ID: 12794269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.